[Ip-health] Fw: MSF invite for upcoming Satellite at IAS Cape Town on Access to Treatment and the Challenges of Long-Term Survival on Antiretrovirals

[Leyla.POPE@geneva.msf.org]

=0D
=0D
The Emergency Is Not Over: Access to Treatment and the Challenges of=0D
Long-Term Survival on Antiretrovirals=0D
=0D
MSF Satellite Session at IAS 2009 - Sunday 19 July, 17:00-19:00=0D
5th IAS Conference on HIV Pathogenesis,=0D
Treatment and Prevention, Cape Town, South Africa=0D
=0D
M=C3=A9decins Sans Fronti=C3=A8res (MSF) =E2=80=93 Satellite Session (SUSAT=
17)=0D
Venue: Mini Room 3, CTICC =E2=80=93 Time: Sunday 19 July, 17:00-19:00=0D
=0D
Over the past decade, due to global public pressure, an estimated three=0D
million people have been initiated on antiretroviral treatment (ART). While=
=0D
this represents considerable progress, seven million people are still=0D
waiting for first line ART. At the same time, a growing number of people=0D
who have been able to access ART are starting to reach the limits of their=
=0D
current treatment. This satellite will explore what it will take to ensure=
=0D
long-term survival on ART in resource-limited settings, as well as the=0D
major threats towards realising this goal.=0D
=0D
=C2=B7     Chair: Dr. Alexandra Calmy, Switzerland=0D
=C2=B7     Co-Chair: Dr Graeme Meintjes, South Africa=0D
=0D
=C2=B7     Simply extending our lives for a few years is not enough; Nokhwe=
zi=0D
Noboyi, Treatment Action Campaign, South Africa=0D
=0D
=C2=B7     Programmatic challenges to improving first line, access to viral=
 load=0D
and managing treatment failure; Dr. Gilles Van Cutsem, MSF South Africa=0D
=0D
=C2=B7     Perspectives for new antiretrovirals in resource-limited setting=
s;=0D
Dr. Bernard Hirschel, Geneva University Hospital, Switzerland=0D
=0D
=C2=B7     Current and future access to viral load testing in resource-limi=
ted=0D
settings; Maurine Murtagh, Clinton Foundation, U.S.=0D
=0D
=C2=B7     Overcoming patent barriers to improve access to new antiretrovir=
al=0D
formulations and combinations; Ellen =E2=80=98t Hoen, UNITAID, Switzerland=
=0D
=0D
=C2=B7     How can governments ensure access to more robust first line,=0D
alternative regimens and improve monitoring tools in times of economic=0D
crisis; Dr. Fran=C3=A7ois Venter, Southern African HIV Clinicians Society, =
South=0D
Africa=0D
=0D
To find out more go to this link:=0D
http://www.msfaccess.org/index.php?id=3D752=0D
=0D
Thanks=0D
Leyla Pope=0D
Communications Officer=0D
M=C3=A9decins Sans Fronti=C3=A8res=0D
Campaign for Access to Essential Medicines=0D
Tel. + 41(0) 22 849 89 88